Elsevier– the world-leading provider of scientific, technical, and medical information products and services – has announced that registration to the 2nd Middle East Vaccine Congress is now open. Organized in cooperation with global communications and event management company MCI Middle East, the conference is slated to be held on 14th-15th December, 2012, at the Rotana Beach Hotel & Resort in Abu Dhabi, UAE.
The 2nd Middle East Vaccine Congress will bring together experts from the healthcare industry, academia and government to address key topics ranging from vaccine research and manufacturing, to vaccination health and governmental policy, safety and regulation. Featured speakers include senior representatives of international and regional healthcare regulators, universities’ medical faculties and healthcare service providers, among others.
“As a professional congress organizer, Elsevier aims to create enabling platforms through which the MENA healthcare industry can benefit from the distilled experience of worldwide professionals,” said Haifa Al Mughrabi, Regional Director of Elsevier. “By bringing the region’s medical professionals and companies up to speed on the latest vaccination practices, breakthroughs and opportunities, we hope to open new channels of cooperation among academics and researchers, regulatory and governmental agencies, charities, and health and industry professionals to strengthen the quality and effectiveness of healthcare in the MENA region.”
In addition to learning from experts, opinion leaders and exhibiting organizations, attendees of the two-day conference will have access to unique, high-quality content and industry updates; meet with a range of exhibitors presenting cutting-edge products and services; and learn about the development of vaccines for infectious diseases.
Early bird registration is currently open until 15th October; late registration is open until 6th December; and onsite registration is available. To register online, please visit www.vaccinecongress.ae.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The Company works in partnership with global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively. A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The Company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
MCI is a globally integrated Association, Communication and Event Management Company. Since 1987, MCI has created corporate events, meetings and incentives; association and governmental conventions, congresses, exhibitions; and managed and provided consulting to associations. MCI’s mission is to help companies, governments and associations bring people together to create meaningful connections and win.
MCI provides many stand-alone solutions designed for those who only need a specific service to complete their projects such as Destination Management, Sustainability Services, Technical and Creative Production, Event Hospitality, Event Furniture and Decoration and Registration Technology.
Visit the MCI website www.mci-group.com
for more information.